The proportion of MAGE-B5 mRNA expression was highest in epithelial neoplasms, followed by carcinosarcomas and mesenchymal neoplasms, with proportions of 84.2% (16/19), 75.0% (2/3), and 50% (1/2), respectively. This evidence concerns the gene MAGEB5 and epithelial neoplasm.